3rd Quarter 2019
Key topics in this quarter’s edition include:
- Brolucizumab - Treatment of wet age-related macular degeneration (AMD)
- Ubrogepant - Acute treatment of migraine headaches
- Luspatercept - Treatment of beta-thalassemia-associated or myelodysplastic syndromes-associated anemia
- Cabotegravir/rilpivirine – Treatment of human immunodeficiency virus (HIV)-1 infection
Top